{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:48:40Z","timestamp":1790765320072,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"vor","delay-in-days":273,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.pbb.2010.05.022","type":"journal-article","created":{"date-parts":[[2010,6,2]],"date-time":"2010-06-02T01:37:08Z","timestamp":1275442628000},"page":"306-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Systemic administration of GMP induces anxiolytic-like behavior in rats"],"prefix":"10.1016","volume":"96","author":[{"given":"Roberto Farina","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Junior","given":"Victor Hermes","family":"Cereser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Berger","family":"Faraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Elisa","family":"B\u00f6hmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo Onofre","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Ganzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2010.05.022_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-3565(25)21332-5","article-title":"Guanine nucleotides are competitive inhibitors of N-Methyl-D-Aspartate at its receptor site both in vitro and in vivo","volume":"250","author":"Baron","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2010.05.022_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0924-977X(03)00100-7","article-title":"Glutamate and anxiety","volume":"14","author":"Bergink","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2010.05.022_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2010.05.022_bib4","first-page":"1112","article-title":"Glutamate receptor ligands as anxiolytics","volume":"2","author":"Chojnacka-Wojcik","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pbb.2010.05.022_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behaviour for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2010.05.022_bib6","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1046\/j.1460-9568.2003.02667.x","article-title":"Antidepressant and anxiolyticlike effects in mice lacking the group III metabotropic glutamate receptor mGluR7","volume":"11","author":"Cryan","year":"2003","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.pbb.2010.05.022_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2010.05.022_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1020728203682","article-title":"Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions","volume":"22","author":"Frizzo","year":"2002","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pbb.2010.05.022_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(03)02506-X","article-title":"Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake","volume":"972","author":"Frizzo","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2010.05.022_bib10","first-page":"248","article-title":"Anxiety Disorders: A Comprehensive Review of Pharmacotherapies Mt Sinai","volume":"75","author":"Hoffman","year":"2008","journal-title":"J Med"},{"key":"10.1016\/j.pbb.2010.05.022_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.tins.2006.07.005","article-title":"Different molecular cascades in different sites of the brain control memory consolidation","volume":"29","author":"Izquierdo","year":"2006","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.1016\/j.pbb.2010.05.022_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00213-008-1121-z","article-title":"Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: effects of GYKI 52466 and its novel analogues","volume":"198","author":"Kapus","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2010.05.022_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-2999(91)90141-C","article-title":"NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations","volume":"193","author":"Kehne","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2010.05.022_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(01)02734-2","article-title":"Effect of orally administered guanosine on seizures and death induced by glutamatergic agents","volume":"912","author":"Lara","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2010.05.022_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pbb.2010.05.022_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(97)00225-5","article-title":"GMP protects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum","volume":"225","author":"Malcon","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2010.05.022_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneuro0355","article-title":"Mechanisms of disease: astrocytes in neurodegenerative disease","volume":"2","author":"Maragakis","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.pbb.2010.05.022_bib18","first-page":"14","article-title":"The role of glutamate in epilepsy and other CNS disorders","volume":"44","author":"Meldrum","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2010.05.022_bib19","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1021\/bi051084x","article-title":"Binding of 5\u2032-GMP to the GluR2 AMPA receptor: insight from targeted molecular dynamics simulations","volume":"44","author":"Mendieta","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbb.2010.05.022_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1192\/bjp.179.5.390","article-title":"New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder","volume":"179","author":"Nutt","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pbb.2010.05.022_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0301-0082(97)00085-3","article-title":"Glutamate receptor in the mammalian central nervous system","volume":"54","author":"Ozawa","year":"1998","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2010.05.022_bib22","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/j.1460-2075.1996.tb00499.x","article-title":"Identification of an extracellular motif involved in the binding of guanine nucleotides by a glutamate receptor","volume":"15","author":"Paas","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.pbb.2010.05.022_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2007.04.007","article-title":"Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs","volume":"115","author":"Palucha","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2010.05.022_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-5793(94)01208-3","article-title":"Differential effects of guanine nucleotides on kainic acid binding and on adenylate cyclase activity in chick optic tectum","volume":"355","author":"Paz","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pbb.2010.05.022_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0924-977X(94)90299-2","article-title":"Effects of antagonists at the NMDA receptor complex in two models of anxiety","volume":"4","author":"Plaznik","year":"1994","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2010.05.022_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1986","journal-title":"J of Neurosci Methods"},{"key":"10.1016\/j.pbb.2010.05.022_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(01)03368-6","article-title":"Guanine based purines inhibit [H] glutamate and [H]AMPA binding at postsynaptic densities from cerebral cortex of rats","volume":"928","author":"Porci\u00fancula","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2010.05.022_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2010.05.022_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1023\/A:1022430501454","article-title":"Effects of guanine nucleotides on glutamate induced chemiluminescence in rat hippocampal slices submitted to hypoxia","volume":"23","author":"Regner","year":"1998","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pbb.2010.05.022_bib30","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1097\/00001756-200008030-00038","article-title":"Guanosine impairs inhibitory avoidance performance in rats","volume":"11","author":"Roesler","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2010.05.022_bib31","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/00001756-199609020-00004","article-title":"GMP reverses the facilitatory effect of glutamate on inhibitory avoidance task in rats","volume":"7","author":"Rubin","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2010.05.022_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nlm.2005.10.006","article-title":"Amnesic effect of GMP depends on its conversion to guanosine","volume":"85","author":"Saute","year":"2006","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.pbb.2010.05.022_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0006-8993(00)02106-5","article-title":"Guanosine and GMP prevent seizures induced by quinolinic acid in mice","volume":"864","author":"Schmidt","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2010.05.022_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11064-004-9687-2","article-title":"Intracerebroventricular guanine-based purines protect against seizures induced by quinolinic acid in mice","volume":"30","author":"Schmidt","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pbb.2010.05.022_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pharmthera.2007.07.004","article-title":"Proposal of a guanine-based purinergic system in the mammalian central nervous system","volume":"116","author":"Schmidt","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2010.05.022_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2008.07.091","article-title":"Antinociceptive effects of intracerebroventricular administration of guanine-based purines in mice: evidences for the mechanism of action","volume":"1234","author":"Schmidt","year":"2008","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pbb.2010.05.022_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1476-5381.2008.00025.x","article-title":"Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors","volume":"156","author":"Schmidt","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pbb.2010.05.022_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0047-6374(00)00225-6","article-title":"Glutamatergic neurotransmission in aging: a critical perspective","volume":"122","author":"Segovia","year":"2001","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.pbb.2010.05.022_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","article-title":"The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention","volume":"51","author":"Sheldon","year":"2007","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pbb.2010.05.022_bib40","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainres.2004.01.053","article-title":"Anticonvulsant effect of GMP depends on its conversion to guanosine","volume":"1005","author":"Soares","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2010.05.022_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02896847","article-title":"Effects of guanine nucleotides on kainic acid binding and on adenylate cyclase in chick optic tectum and cerebellum","volume":"3","author":"Souza","year":"1991","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pbb.2010.05.022_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1358\/dnp.2004.17.4.829052","article-title":"mGlu5 receptor antagonists: a novel class of anxiolytics?","volume":"17","author":"Spooren","year":"2004","journal-title":"Drug News Perspect"},{"issue":"2","key":"10.1016\/j.pbb.2010.05.022_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/rmv.454","article-title":"Factors affecting delivery of antiviral drugs to the brain","volume":"15","author":"Strazielle","year":"2005","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.pbb.2010.05.022_bib44","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/jpet.300.3.918","article-title":"Human organic anion transporters and human organic cation transporters mediate renal antiviral transport","volume":"300","author":"Takeda","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2010.05.022_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00001756-199501000-00006","article-title":"Guanine nucleotides inhibit the stimulation of GFAP phosphorylation by glutamate","volume":"6","author":"Tasca","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2010.05.022_bib46","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjp.0703923","article-title":"Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist","volume":"132","author":"Tatarczynska","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2010.05.022_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002130100798","article-title":"The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration","volume":"158","author":"Tatarczynska","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2010.05.022_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bbr.2004.03.008","article-title":"Guanosine selectively inhibits locomotor stimulation induced by the NMDA antagonist dizocilpine","volume":"154","author":"Tort","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2010.05.022_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0006-8993(03)02769-0","article-title":"Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice","volume":"977","author":"Vinad\u00e9","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2010.05.022_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jnr.20327","article-title":"Effects of chronic administered guanosine on behavioral parameters and brain glutamate uptake in rats","volume":"79","author":"Vinad\u00e9","year":"2005","journal-title":"J Neurosci Res"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305710001693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305710001693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:29:25Z","timestamp":1758774565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305710001693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0091305710001693"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2010.05.022","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic administration of GMP induces anxiolytic-like behavior in rats","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2010.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}